EODData

FRA, TCE2: Celldex Therapeutics Inc

21 Aug 2026
LAST:

33.65

CHANGE:
 1.56
OPEN:
33.65
HIGH:
33.65
ASK:
0.00
VOLUME:
0
CHG(%):
4.43
PREV:
35.21
LOW:
33.65
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Aug 2633.6533.6533.6533.650
20 Aug 2635.2135.2135.2135.210
19 Aug 2635.5035.5035.5035.500
18 Aug 2635.6335.6335.6335.630
17 Aug 2635.6235.6235.6235.620
14 Aug 2636.3236.3236.3236.320
13 Aug 2638.3438.3438.3438.340
12 Aug 2637.8537.8537.8537.850
07 Aug 2635.5436.3635.5436.360
06 Aug 2635.0035.0035.0035.000

PROFILE

Name:Celldex Therapeutics Inc
About:Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. Its clinical development programs are Barzolvolimab (CDX-0159), a monoclonal antibody that specifically binds the KIT receptor and potently inhibits its activity for treating chronic urticarias, prurigo nodularis, eosinophilic esophagitis, and atopic dermatitis; and CDX-622, a bispecific candidate for inflammatory diseases, which targets two complementary pathways that drive chronic inflammation, potently neutralizing the alarmin thymic stromal lymphopoietin and depleting mast cells through stem cell factor starvation. The company is headquartered in Hampton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:Perryville III Building, Hampton, NJ, United States, 08827
Website:https://www.celldex.com
ISIN:US15117B2025

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:-8.63 
Forward P/E:-19.45 
PEG Ratio:-0.81 
Price to Sales:16,724.81 
Price to Book:4.27 
Operating Margin:-3,664.68 
Return on Assets:-0.28 
Return on Equity:-0.44 
Revenue:135.0K 
Shares:66.41M 
Market Cap:2.235B 

TECHNICAL INDICATORS

MA5:35.124.4%
MA10:35.956.8%
MA20:33.780.4%
MA50:31.407.2%
MA100:29.2515.0%
MA200:25.9129.9%
STO14:22.86
RSI14:55.60
WPR14:-77.14
MTM14:0.70
ROC14:0.02 
ATR:0.87 
Week High:36.327.9%
Week Low:33.650.0%
Month High:38.3413.9%
Month Low:29.3829.9%
Year High:38.3413.9%
Year Low:17.8089.0%
Volatility:4.26 

RECENT SPLITS

Date Ratio
11 Feb 20191-15